Daiichi Sankyo Raises Dementia Awareness In Japan
This article was originally published in PharmAsia News
Daiichi Sankyo March 17 launched a dementia awareness campaign in Japan using television commercials and a website to introducing its new treatment options to improve quality of life for dementia patients.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.